As a result of China's transition away from a "zero COVID" policy of lockdowns and toward acceptance that the virus is now endemic, the HIV drug Azvudine has been approved for treating COVID patients.
According to Reuters, citing the National Medical Products Administration, China on Monday issued the go-ahead to repurpose a drug that is generally used to treat specific HIV-1 virus infections for "normal type" COVID infections.
Genuine Biotech's drug, Azvudine, was approved to treat p...
